Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Preferred Dividend Payments (2021)

Historic Preferred Dividend Payments for Zevra Therapeutics (ZVRA) over the last 1 years, with Q2 2021 value amounting to $16.9 million.

  • Zevra Therapeutics' Preferred Dividend Payments changed N/A to $16.9 million in Q2 2021 from the same period last year, while for Mar 2022 it was $16.9 million, marking a year-over-year decrease of 5487.13%. This contributed to the annual value of $54.3 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q2 2021, Zevra Therapeutics' Preferred Dividend Payments is $16.9 million.
  • Zevra Therapeutics' 5-year Preferred Dividend Payments high stood at $37.4 million for Q1 2021, and its period low was $16.9 million during Q2 2021.